Literature DB >> 17269940

Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.

A M Al Hammadi, S Sallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17269940     DOI： 10.1111/j.1538-7836.2007.02353.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.

Authors:  Reut Gurion; Anita Siu; Aaron R Weiss; Margaret Masterson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

Review 2.  Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.

Authors:  Jeong A Park
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

Review 3.  Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients.

Authors:  Jeong A Park
Journal:  Korean J Pediatr       Date:  2016-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.